NAVA.OL लाइव सिग्नल्स | Getagraph.com के साथ लाभ को अधिकतम करें

खरीदें 1215 min ago

@ Kr.33.40

जारी किया गया: 6 May 2024 @ 17:57

वापसी: -1.80%

पिछला सिग्नल: May 6 - 15:53

पिछला सिग्नल: बेचें

वापसी: 0.00 %

Live Chart Being Loaded With Signals

Commentary (7 May 2024 @ 13:23):
Our systems believe the stock currently is undervalued by 2.34% compare to its pairs and should correct upwards.

Stats
आज की मात्रा	1 400.00
औसत मात्रा	86 862.00
बाजार मूल्य	554.78M
EPS	Kr.0.390 ( 2023-11-01 )
अगली कमाई की तारीख	( Kr.0 ) 2024-05-31
Last Dividend	Kr.0.998 ( 2010-04-13 )
Next Dividend	Kr.0 ( N/A )
P/E	27.80
ATR14	Kr.0.385 (1.17%)

सहसंबंध (AI algo v.1.1b): Undervalued: 2.34% Kr.33.57 paired level. (एल्गो वास्तविक समय में सबसे अधिक सहसंबंधित स्टॉक्स के परिवर्तनों का ट्रैक करता है और तत्काल अद्यतन देता है)

मात्रा सहसंबंध

लंबा: 1.00 (very strong)

छोटा: 0.00 (neutral)

Signal:(0) Neutral

Navamedic ASA सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध
NORSE.OL	0.895
SMOP.OL	0.871
NTEL.OL	0.871
TOM.OL	0.868
ENDUR.OL	0.839
XXL.OL	0.838
KIT.OL	0.832
SNI.OL	0.826
BORR.OL	0.815
AYFIE.OL	0.813

10 सबसे अधिक नकारात्मक सहसंबंध
AKBM.OL	-0.895
ODL.OL	-0.895
SCATC.OL	-0.893
SBX.OL	-0.87
OKEA.OL	-0.858
VOLUE.OL	-0.857
PHO.OL	-0.854
FRO.OL	-0.852
TRVX.OL	-0.846
XPLRA.OL	-0.842

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

Navamedic ASA सहसंबंध - मुद्रा/वस्त्र

-0.83
( strong negative )

-0.82
( strong negative )

0.00
( neutral )

-0.86
( strong negative )

0.64
( weak )

Navamedic ASA वित्तीय

Annual	2023
राजस्व:	Kr.512.00M
सकल लाभ:	Kr.123.46M (24.11 %)
EPS:	Kr.0.190

FY	2023
राजस्व:	Kr.512.00M
सकल लाभ:	Kr.123.46M (24.11 %)
EPS:	Kr.0.190

FY	2022
राजस्व:	Kr.382.14M
सकल लाभ:	Kr.163.52M (42.79 %)
EPS:	Kr.1.750

FY	2021
राजस्व:	Kr.278.44M
सकल लाभ:	Kr.111.74M (40.13 %)
EPS:	Kr.0.00774

Financial Reports:

No articles found.

Navamedic ASA Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
Kr.0 (N/A)	Kr.0 (N/A)	Kr.0 (N/A)	Kr.0 (N/A)	Kr.0 (N/A)	Kr.0 (N/A)	Kr.0 (N/A)	Kr.0 (N/A)	Kr.0 (N/A)	Kr.0 (N/A)

Navamedic ASA Dividend Information - No Dividend Player

Dividend Sustainability Score: 2.56 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future

Information

First Dividend	Kr.0.998	2010-04-13
Last Dividend	Kr.0.998	2010-04-13
Next Dividend	Kr.0	N/A
Payout Date	2010-04-27
Next Payout Date	N/A
# dividends	1	--
Total Paid Out	Kr.0.998	--
Avg. Dividend % Per Year	0.00%	--
Score	0.07	--
Div. Sustainability Score	2.56
Div.Growth Potential Score	0
Div. Directional Score	0.187	--

Next Divdend (Est)
(2024-05-07)

Kr.0 Estimate 0.00 %

Dividend Stability

0.00 Very Bad

Dividend Score

0.07

Pay Frequency

Insufficient data to determine frequency

Yearly Payout

Year	Amount	Yield
2010	Kr.0.998	17.80%
2011	Kr.0	0.00%
2012	Kr.0	0.00%
2013	Kr.0	0.00%
2014	Kr.0	0.00%
2015	Kr.0	0.00%
2016	Kr.0	0.00%
2017	Kr.0	0.00%
2018	Kr.0	0.00%
2019	Kr.0	0.00%
2020	Kr.0	0.00%
2021	Kr.0	0.00%
2022	Kr.0	0.00%
2023	Kr.0	0.00%
2024	Kr.0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for OSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
ALNG.OL	Dividend King	2023-11-27	Quarterly	2	6.60%	7.04
OKEA.OL	Dividend Knight	2023-12-01	Quarterly	3	5.65%	6.86
SALM.OL	Dividend Knight	2023-06-09	Annually	17	2.80%	4.97
BWLPG.OL	Dividend Knight	2023-11-17	Quarterly	11	1.68%	4.46
BWO.OL	Dividend Knight	2023-11-20	Quarterly	14	0.87%	3.96
ATEA.OL	Dividend Knight	2023-11-20	Annually	16	2.97%	3.45
HAFNI.OL	Dividend Knight	2023-11-23	Semi-Annually	5	1.18%	3.31
AKER.OL	Dividend Knight	2023-11-07	Semi-Annually	20	2.99%	3.13
AUSS.OL	Dividend Knight	2023-05-26	Annually	17	3.23%	2.93
GSF.OL	Dividend Knight	2023-06-28	Annually	15	3.81%	2.67

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.0224	1.500	-0.448	-0.672	[0 - 0.5]
returnOnAssetsTTM	-0.0213	1.200	-0.711	-0.853	[0 - 0.3]
returnOnEquityTTM	-0.0521	1.500	-1.690	-2.54	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	1.378	0.800	8.11	6.49	[1 - 3]
quickRatioTTM	0.439	0.800	-2.12	-1.698	[0.8 - 2.5]
cashRatioTTM	0.146	1.500	-0.298	-0.447	[0.2 - 2]
debtRatioTTM	0.275	-1.500	5.41	-8.12	[0 - 0.6]
interestCoverageTTM	1.577	1.000	-0.527	-0.527	[3 - 30]
operatingCashFlowPerShareTTM	-0.622	2.00	-0.207	-0.415	[0 - 30]
freeCashFlowPerShareTTM	-0.740	2.00	-0.370	-0.740	[0 - 20]
debtEquityRatioTTM	0.653	-1.500	7.39	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.243	1.000	9.29	9.29	[0.2 - 0.8]
operatingProfitMarginTTM	0.0227	1.000	-1.546	-1.546	[0.1 - 0.6]
cashFlowToDebtRatioTTM	-0.0727	1.000	-1.515	-1.515	[0.2 - 2]
assetTurnoverTTM	0.952	0.800	6.99	5.59	[0.5 - 2]
Total Score				2.56

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-50.70	1.000	-5.22	0	[1 - 100]
returnOnEquityTTM	-0.0521	2.50	-1.087	-2.54	[0.1 - 1.5]
freeCashFlowPerShareTTM	-0.740	2.00	-0.247	-0.740	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-0.622	2.00	-0.207	-0.415	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-0.822	1.500	-8.82	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	-0.0210	1.000	-3.03	0	[0.1 - 0.5]
Total Score				-2.19

Navamedic ASA

Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Northern Europe. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic acidemia/propionic acidemia, glutaric aciduria, isovaleric acidemia, and urea cycle disorders, as well as products for glycogen storage diseases and renal diseases, fat metabolism, malnutrition, and ketogenic diet. In addition, the company provides consumer health products consisting of non-prescription drugs and health care products for pain relief, cough and cold, gastro, women's health, and others primarily through pharmacies and drugstores; specialty pharmaceutical products in various therapeutic areas comprising dermatology, wound care, women's health, urology, and obesity; and branded generics, including cardiology products and antibiotics. It sells, markets, and distributes its products to hospitals, patients, and pharmacies. The company was formerly known as Glucomed AS and changed its name to Navamedic ASA in 2004. Navamedic ASA was incorporated in 2002 and is headquartered in Oslo, Norway.